FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3038411417> ?p ?o ?g. }

• W3038411417 endingPage "1524" @default.
• W3038411417 startingPage "1519" @default.
• W3038411417 abstract "Objective It has been hypothesised that the use of ACE inhibitors and angiotensin receptor blockers (ARBs) might either increase or reduce the risk of severe or lethal COVID-19. The findings from the available observational studies varied, and summary estimates are urgently needed to elucidate whether these drugs should be suspended during the pandemic, or patients and physicians should be definitely reassured. This meta-analysis of adjusted observational data aimed to summarise the existing evidence on the association between these medications and severe/lethal COVID-19. Methods We searched MedLine, Scopus and preprint repositories up to 8 June 2020 to retrieve cohort or case–control studies comparing the risk of severe/fatal COVID-19 (either mechanical ventilation, intensive care unit admission or death), among hypertensive subjects treated with: (1) ACE inhibitors, (2) ARBs and (3) both, versus untreated subjects. Data were combined using a random-effect generic inverse variance approach. Results Ten studies, enrolling 9890 hypertensive subjects were included in the analyses. Compared with untreated subjects, those using either ACE inhibitors or ARBs showed a similar risk of severe or lethal COVID-19 (summary OR: 0.90; 95% CI 0.65 to 1.26 for ACE inhibitors; 0.92; 95% CI 0.75 to 1.12 for ARBs). The results did not change when both drugs were considered together, when death was the outcome and excluding the studies with significant, divergent results. Conclusion The present meta-analysis strongly supports the recommendation of several scientific societies to continue ARBs or ACE inhibitors for all patients, unless otherwise advised by their physicians who should thus be reassured." @default.
• W3038411417 created "2020-07-10" @default.
• W3038411417 creator A5003282294 @default.
• W3038411417 creator A5046959234 @default.
• W3038411417 creator A5051216389 @default.
• W3038411417 creator A5074984739 @default.
• W3038411417 creator A5080034360 @default.
• W3038411417 creator A5080579032 @default.
• W3038411417 creator A5084987842 @default.
• W3038411417 creator A5087266836 @default.
• W3038411417 creator A5090804111 @default.
• W3038411417 date "2020-07-01" @default.
• W3038411417 modified "2023-10-15" @default.
• W3038411417 title "Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis" @default.
• W3038411417 cites W2187548599 @default.
• W3038411417 cites W2344534501 @default.
• W3038411417 cites W2923736418 @default.
• W3038411417 cites W3008028633 @default.
• W3038411417 cites W3008090866 @default.
• W3038411417 cites W3008827533 @default.
• W3038411417 cites W3009799538 @default.
• W3038411417 cites W3009976289 @default.
• W3038411417 cites W3011862945 @default.
• W3038411417 cites W3013231340 @default.
• W3038411417 cites W3013302817 @default.
• W3038411417 cites W3013564424 @default.
• W3038411417 cites W3014662258 @default.
• W3038411417 cites W3015590289 @default.
• W3038411417 cites W3016572296 @default.
• W3038411417 cites W3016783119 @default.
• W3038411417 cites W3019844653 @default.
• W3038411417 cites W3019981210 @default.
• W3038411417 cites W3021992825 @default.
• W3038411417 cites W3022028821 @default.
• W3038411417 cites W3023640683 @default.
• W3038411417 cites W3023751598 @default.
• W3038411417 cites W3023787531 @default.
• W3038411417 cites W3023826646 @default.
• W3038411417 cites W3025099648 @default.
• W3038411417 cites W3030177929 @default.
• W3038411417 cites W3033263367 @default.
• W3038411417 cites W3035790792 @default.
• W3038411417 cites W3080783441 @default.
• W3038411417 doi "https://doi.org/10.1136/heartjnl-2020-317336" @default.
• W3038411417 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7371482" @default.
• W3038411417 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32611676" @default.
• W3038411417 hasPublicationYear "2020" @default.
• W3038411417 type Work @default.
• W3038411417 sameAs 3038411417 @default.
• W3038411417 citedByCount "81" @default.
• W3038411417 countsByYear W30384114172020 @default.
• W3038411417 countsByYear W30384114172021 @default.
• W3038411417 countsByYear W30384114172022 @default.
• W3038411417 countsByYear W30384114172023 @default.
• W3038411417 crossrefType "journal-article" @default.
• W3038411417 hasAuthorship W3038411417A5003282294 @default.
• W3038411417 hasAuthorship W3038411417A5046959234 @default.
• W3038411417 hasAuthorship W3038411417A5051216389 @default.
• W3038411417 hasAuthorship W3038411417A5074984739 @default.
• W3038411417 hasAuthorship W3038411417A5080034360 @default.
• W3038411417 hasAuthorship W3038411417A5080579032 @default.
• W3038411417 hasAuthorship W3038411417A5084987842 @default.
• W3038411417 hasAuthorship W3038411417A5087266836 @default.
• W3038411417 hasAuthorship W3038411417A5090804111 @default.
• W3038411417 hasBestOaLocation W30384114171 @default.
• W3038411417 hasConcept C126322002 @default.
• W3038411417 hasConcept C17744445 @default.
• W3038411417 hasConcept C177713679 @default.
• W3038411417 hasConcept C194828623 @default.
• W3038411417 hasConcept C199539241 @default.
• W3038411417 hasConcept C201903717 @default.
• W3038411417 hasConcept C23131810 @default.
• W3038411417 hasConcept C2776376669 @default.
• W3038411417 hasConcept C2777080012 @default.
• W3038411417 hasConcept C2779134260 @default.
• W3038411417 hasConcept C2779473830 @default.
• W3038411417 hasConcept C3008058167 @default.
• W3038411417 hasConcept C524204448 @default.
• W3038411417 hasConcept C71924100 @default.
• W3038411417 hasConcept C89623803 @default.
• W3038411417 hasConcept C95190672 @default.
• W3038411417 hasConceptScore W3038411417C126322002 @default.
• W3038411417 hasConceptScore W3038411417C17744445 @default.
• W3038411417 hasConceptScore W3038411417C177713679 @default.
• W3038411417 hasConceptScore W3038411417C194828623 @default.
• W3038411417 hasConceptScore W3038411417C199539241 @default.
• W3038411417 hasConceptScore W3038411417C201903717 @default.
• W3038411417 hasConceptScore W3038411417C23131810 @default.
• W3038411417 hasConceptScore W3038411417C2776376669 @default.
• W3038411417 hasConceptScore W3038411417C2777080012 @default.
• W3038411417 hasConceptScore W3038411417C2779134260 @default.
• W3038411417 hasConceptScore W3038411417C2779473830 @default.
• W3038411417 hasConceptScore W3038411417C3008058167 @default.
• W3038411417 hasConceptScore W3038411417C524204448 @default.
• W3038411417 hasConceptScore W3038411417C71924100 @default.
• W3038411417 hasConceptScore W3038411417C89623803 @default.
• W3038411417 hasConceptScore W3038411417C95190672 @default.
• W3038411417 hasIssue "19" @default.

• next